Abeona Therapeutics Inc.
ABEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $229 | $107 | $24 | $33 |
| - Cash | $23 | $14 | $14 | $33 |
| + Debt | $23 | $5 | $8 | $9 |
| Enterprise Value | $228 | $98 | $18 | $10 |
| Revenue | $0 | $4 | $1 | $3 |
| % Growth | -100% | 147.5% | -52.9% | – |
| Gross Profit | -$3 | $2 | $1 | $3 |
| % Margin | – | 54.1% | 68.2% | 100% |
| EBITDA | -$57 | -$51 | -$34 | -$77 |
| % Margin | – | -1,444.9% | -2,431.6% | -2,560.5% |
| Net Income | -$64 | -$54 | -$40 | -$85 |
| % Margin | – | -1,548.2% | -2,807.4% | -2,831.2% |
| EPS Diluted | -1.55 | -2.53 | -5.53 | -21.5 |
| % Growth | 38.7% | 54.2% | 74.3% | – |
| Operating Cash Flow | -$56 | -$37 | -$43 | -$66 |
| Capital Expenditures | -$2 | -$0 | -$0 | -$4 |
| Free Cash Flow | -$58 | -$37 | -$44 | -$70 |